What is our policy on Open Science and how do we work with independent researchers?
We are fully committed to Open Science
How will we make psilocybin therapy accessible to all who need it, not just those who can afford it?
Our priority is, and will always be, to help patients
How do we train our therapists and do we require them to have personal experience with psilocybin?
Psilocybin therapy requires specially trained, compassionate therapists.
Why do we seek patent protection?
Patents drive innovation and bring new therapies to patients
Should psilocybin be legalised?
We have a responsibility to bring this innovation to patients as quickly as possible, but in a way that prioritises safety, efficacy, quality, and accessibility